S&E, Receives

S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial

Veröffentlicht: 07.08.2025 um 18:06 Uhr, prnewswire.co.uk

S&E bio Co., Ltd. New York South Korea

View original content:https://www.prnewswire.co.uk/news-releases/se-bio-receives-koreas-first-approval-for-exosome-based-therapy-clinical-trial-302442565.html

en | boerse | 67950265 |